Tirat Carmel Mental Health Center
14
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.1%
1 terminated/withdrawn out of 14 trials
91.7%
+5.2% vs industry average
50%
7 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Indirect Evaluation of Lithium Level in Blood Using Non-invasive Sweat Biosensors
Role: lead
Analysis of Sweat Secretion and Body Dehydration Monitoring
Role: lead
Clinical, Psychological and Genetic Characteristics in Dermatological Patients
Role: collaborator
Spectrophon LTD Glucometry Monitor Accuracy
Role: lead
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Role: collaborator
Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients
Role: lead
Metoclopramide as Treatment of Clozapine-induced Hypersalivation
Role: collaborator
Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders
Role: collaborator
Pyridoxal Kinase Activity in Tardive Dyskinesia
Role: collaborator
Efficacy and Safety Curcumin in Depression
Role: collaborator
Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
Role: collaborator
Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
Role: lead
A Study of the Association Between Tobacco Smoking and Bipolar Affective Disorder
Role: lead
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia
Role: collaborator
All 14 trials loaded